Interpace Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of IDXG for the last quarter is 10.28 M USD, and it's 13.27% higher compared to the previous quarter. The net income of Q4 23 is 889.00 k USD.